---
title: "Bionomics (BNOX.US)"
type: "quote"
locale: "en"
url: "https://longbridge.com/en/quote/BNOX.US.md"
symbol: "BNOX.US"
name: "Bionomics"
industry: "Biotechnology"
---

# Bionomics (BNOX.US)

| Item | Detail |
|------|--------|
| Industry | Biotechnology |

## Company Profile

Bionomics Limited, a clinical stage biopharmaceutical company, discovers and develops novel drug candidates for the treatment of central nervous system disorders and cancers in Australia. Its lead product candidate includes BNC210, a selective negative allosteric modulator of the a7, which is in pha...

## Valuation Analysis

| Metric | Current | Industry Ranking | High | Median | Low |
|--------|---------|-----------------|------|--------|-----|
| Dividend Yield | 0.00% | - | - | - | - |

## Institutional View

### Target Price Forecast

| Metric | Price |
|--------|-------|
| Current Price | 0.24 |
| Highest Target | 18.14 |
| Lowest Target | 4.01 |

## References

- [Company Overview](https://longbridge.com/en/quote/BNOX.US/overview.md) - Shareholders, executives, business segments
- [Financials](https://longbridge.com/en/quote/BNOX.US/norm.md) - Income statement, balance sheet, cash flow, distribution plan
- [Topics & Discussions](https://longbridge.com/en/quote/BNOX.US/topics.md) - Community topics and discussions

---

> **Disclaimer**: This article is for reference only and does not constitute any investment advice.